The Bombay High Court (HC) has sought a response from the Brihanmumbai Municipal Corporation (BMC) and the state government over allegations made by the Bharatiya Janata Party in a Public Interest Litigation (PIL) filed by Legislative Assembly (MLA) member Ashish Shelar. The PIL claimed that BMC had issued a tender on August 21, 2020 for procurement of medicines and germs for the hospital run by the civil authority, which was not in conformity with the conditions of the World Health Organization and the Central Health Officers. . The PIL also alleges that the quality standards of essential commodities mentioned in the tender have been compromised to benefit the vested interests of the bidders, hence HC should stop the ongoing tender process. The affidavits are to be filed within two weeks in response to the allegations leveled by Shelar in the PIL.
The division bench of Chief Justice Dipankar Dutta and Justice Girish Kulkarni, while hearing the PIL, had informed advocate Deepa Chavan to appear on behalf of Shelar, stating that Kovid-19 was involved and treated patients The ongoing battle had led to hospital-acquired infection (HAI) hospital staff as well as hospitalized patients operated by the civil authority.
The petition stated that one of the reasons for the incidents of HAI was the skewed public procurement process, which is intended to favor certain manufacturers by undermining standards regarding eligibility / predetermined criteria. The PIL claimed that the health and safety of the common people, especially the economically disadvantaged sections of the society, was compromised due to the skewed process and even though Shelar had taken the best possible medicines and disinfectants in a transparent, fair manner There were suggestions to resolve the purchase issue. And properly regulated process, it became unheard of and hence PIL.
PIL has given guidelines to the state and BMC to follow the specifications and standard operating procedures developed by the infection control committee of the Directorate of Medical Education and Research (DMER) in October 2019. , Disinfectant as per the rate contract for antiseptic and disinfectant, developed by Hafken Biopharmaceuticals, Maharashtra State in March 2019.
The PIL further states that as specified in the tender issued by BMC on August 21, 2020, the tender process should be stopped and all medical including medicines, antiseptics, disinfectants and other medical devices All future purchases of supplies must take place. In compliance with the Central Vigilance Committee (CVC) guidelines, all the conditions for procurement have been strictly directed and adhered to.
After hearing the submissions, the court directed BMC to respond to the allegations leveled by the petitioner within two weeks.